41.59

1.41% 0.58

Kiniksa Pharmaceuticals International Plc (KNSA)

Overview News Price History Option Chain Financials Discussions Forecast

Kiniksa Pharmaceuticals International Plc stock is traded at $41.59, with a volume of 311.61K. It is up +1.41% in the last 24 hours and up +2.49% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Previous Close:

$41.01

Open:

$41.06

24h Volume:

311.61K

Relative Volume:

0.75

Market Cap:

$3.15B

Revenue:

$384.10M

Net Income/Loss:

$-9.07M

P/E Ratio:

-297.07

EPS:

-0.14

Net Cash Flow:

$11.10M

1W Performance:

-0.19%

1M Performance:

+2.49%

6M Performance:

+49.98%

1Y Performance:

+106.50%

1-Day Range:

$40.33

$41.99

1-Week Range:

$40.05

$42.32

52-Week Range:

$17.82

$42.98

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name

Kiniksa Pharmaceuticals International Plc

Sector

Healthcare (1123)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

(781) 431-9100

Address

23 OLD BOND STREET, FLOOR 3, LONDON

Employee

315

Twitter

@kiniksa

Next Earnings Date

2024-10-29

Latest SEC Filings

KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KNSA Kiniksa Pharmaceuticals International Plc	41.59	3.11B	384.10M	-9.07M	11.10M	-0.14
ZTS Zoetis Inc	118.66	51.85B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.33	45.46B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.52	42.70B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	29.79	34.62B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	493.99	21.03B	3.08B	1.24B	1.07B	25.61

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-29-25	Initiated	TD Cowen	Buy
Mar-13-25	Initiated	Citigroup	Buy
Sep-13-24	Initiated	Jefferies	Buy
May-03-24	Initiated	Wells Fargo	Overweight
Jun-29-20	Reiterated	BofA Securities	Buy
Apr-01-20	Initiated	BofA/Merrill	Buy
Mar-11-19	Initiated	Barclays	Overweight
Dec-12-18	Reiterated	Wedbush	Outperform
Jun-19-18	Initiated	JMP Securities	Mkt Outperform

View All

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

Dec 13, 2025

Braidwell LP Sells 860,329 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 13, 2025

Dec 12, 2025

Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates Again - MSN

Dec 12, 2025

Nebula Research & Development LLC Has $1.93 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 12, 2025

Dec 11, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) CFO Sells 42,841 Shares of Stock - MarketBeat

Dec 11, 2025

Dec 10, 2025

Kiniksa Pharma CFO Ragosa sells shares worth $1.77m By Investing.com - Investing.com Nigeria

Dec 10, 2025

Jump Financial LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 10, 2025

Dec 08, 2025